安徽医学
安徽醫學
안휘의학
ANHUI MEDICAL JOURNAL
2014年
5期
559-561
,共3页
张晶晶%郝丽%王德光%秦蓉
張晶晶%郝麗%王德光%秦蓉
장정정%학려%왕덕광%진용
IgA肾病%蛋白尿%临床表现%病理类型%牛津分型
IgA腎病%蛋白尿%臨床錶現%病理類型%牛津分型
IgA신병%단백뇨%림상표현%병리류형%우진분형
IgA nephropathy%Proteinuria%Clinical manifestations%Pathological grading%Oxford pathological grading
目的:探讨表现为小量蛋白尿IgA肾病患者临床表现及牛津病理分型特点。方法80例经肾穿刺活检诊断原发性IgA肾病患者根据其24 h尿蛋白定量结果分为尿蛋白≤500 mg/24 h;500~1000 mg/24 h;>1000 mg/24 h三组,进行临床及病理资料回顾性分析。结果临床特点中尿蛋白量与高血压的发生具有相关性(P<0.05);临床指标中尿蛋白量与估算肾小球率过滤(eGFR)、血浆白蛋白、血红蛋白之间存在相关性(P<0.05);牛津病理分型中各指标与尿蛋白量之间差异无统计学意义。结论对于尿蛋白≤500 mg/24 h 原发性IgA肾病患者的评估尚须进一步明确,对500~1000 mg/24 h需加以重视、强调积极的肾活检及临床干预。
目的:探討錶現為小量蛋白尿IgA腎病患者臨床錶現及牛津病理分型特點。方法80例經腎穿刺活檢診斷原髮性IgA腎病患者根據其24 h尿蛋白定量結果分為尿蛋白≤500 mg/24 h;500~1000 mg/24 h;>1000 mg/24 h三組,進行臨床及病理資料迴顧性分析。結果臨床特點中尿蛋白量與高血壓的髮生具有相關性(P<0.05);臨床指標中尿蛋白量與估算腎小毬率過濾(eGFR)、血漿白蛋白、血紅蛋白之間存在相關性(P<0.05);牛津病理分型中各指標與尿蛋白量之間差異無統計學意義。結論對于尿蛋白≤500 mg/24 h 原髮性IgA腎病患者的評估尚鬚進一步明確,對500~1000 mg/24 h需加以重視、彊調積極的腎活檢及臨床榦預。
목적:탐토표현위소량단백뇨IgA신병환자림상표현급우진병리분형특점。방법80례경신천자활검진단원발성IgA신병환자근거기24 h뇨단백정량결과분위뇨단백≤500 mg/24 h;500~1000 mg/24 h;>1000 mg/24 h삼조,진행림상급병리자료회고성분석。결과림상특점중뇨단백량여고혈압적발생구유상관성(P<0.05);림상지표중뇨단백량여고산신소구솔과려(eGFR)、혈장백단백、혈홍단백지간존재상관성(P<0.05);우진병리분형중각지표여뇨단백량지간차이무통계학의의。결론대우뇨단백≤500 mg/24 h 원발성IgA신병환자적평고상수진일보명학,대500~1000 mg/24 h수가이중시、강조적겁적신활검급림상간예。
Objective To analyse the clinical manifestations and Oxford pathological grading in IgA nephropathy patients with mini-mal proteinuria.Methods The clinical and pathological material of 80 cases of IgA nephropathy patients from this hospital was retrospective-ly analysed,and the patients were divided into 3 groups according to the 24 h urine protein quantitative results:proteinuria:≤500 mg/24 h, 500~1 000 mg/24 h,and>1 000 mg/24 h.Results The proteinuria was related with hypertension(P<0.05).As for the clinical indexes, there was difference among proteinuria with estimated glomerular filtration rate(eGFR),albumin and hemoglobin(P<0.05).As for the path-ological grading,there was no significant difference.Conclusion More studies are needed to evaluate IgA nephropathy with proteinuria≤500 mg/24 h;and clinicians should strengthen the monitoring of the related indicators of the patients with proteinuria 500~1 000 mg/24 h to con-trol the disease.